Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.53371 | 21 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.51345 | 22 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.51235 | 22 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.41202 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.4382 | 20 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.56155 | 21 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.94202 | 38 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.71437 | 32 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.47557 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.49835 | 22 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.50428 | 22 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.5005 | 23 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.50465 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.50428 | 22 |